VNN1 Gene Potentially Useful Biomarker in Childhood Asthma

This article originally appeared here.
Share this content:
<i>VNN1</i> Gene Potentially Useful Biomarker in Childhood Asthma
VNN1 Gene Potentially Useful Biomarker in Childhood Asthma

THURSDAY, April 23, 2015 (HealthDay News) -- Researchers say they've identified a gene that affects whether children with asthma respond to corticosteroids. The study was published online April 21 in the Journal of Allergy and Clinical Immunology.

Researchers analyzed the genomes of 57 children with asthma, and found that the activity of a gene called vanin-1 (VNN1) affected whether they were good or poor responders to corticosteroid treatment.

The gene "may serve as a clinically useful biomarker to identify a subset of difficult-to-treat asthmatic children, and targeting the VNN1 pathway may be useful as a therapeutic strategy," senior author Gurjit Khurana Hershey, M.D., Ph.D., director of the Asthma Research Center at the Cincinnati Children's Hospital Medical Center, said in a hospital news release.

"Difficult-to-treat patients account for over 50 percent of health care costs associated with asthma," Hershey said. "There are new drugs that may be helpful, as well as those that affect the VNN1 pathway, but they have not been tested in asthma." Over-activity of VNN1 is associated with a number of health problems, including inflammatory bowel disease and lupus, the researchers added.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »